Skip to main content
. 2018 May 30;9:1209. doi: 10.3389/fimmu.2018.01209

Table 4.

Analysis of CD38 expression level and survival outcomes in triple negative breast cancers (TNBC) using data from the European Genome–phenome Archive.

Hazard ratio 95% confidence interval pValue
Disease-free survival (DFS)
CD38 (every 1 unit) 0.82 (0.68, 0.97) 0.0229*
Overall survival (OS)
CD38 (every 1 unit) 0.83 (0.72, 0.97) 0.0191*

*Statistically significant.

HHS Vulnerability Disclosure